mhurhangee/ep-ind-claims huggingface dataset:
A computer-implemented data processing method for determining an optimum relative position between an arrangement of at least one beam position and at least a part of a patient's body when the patient is placed for treatment by means of a treatment device which can emit treatment radiation, wherein the at least one beam position describes at least one position of at least one treatment beam, wherein the arrangement is referred to as the treatment arrangement and the treatment beam comprises the treatment radiation, wherein the method is executed by a computer, all steps of the method are executed by the computer, and the method comprises the following steps: a) providing treatment beam absorption data which describe the absorption properties of the at least part of the body with respect to absorbing the treatment radiation, and the relative position between the at least part of the body and the treatment arrangement; b) providing treatment beam data which describe radiation properties of the at least one treatment beam; c) providing condition data which describe a condition for treating the at least part of the body; d) determining an optimum relative position between the treatment arrangement and the at least part of the body on the basis of the condition data, the treatment beam data and the treatment beam absorption data, characterized in that the absorption data are provided by determining the absorption properties of the at least part of the body with respect to absorbing the treatment radiation on the basis of a CT image and by determining the relative position between the at least part of the body and the treatment arrangement on the basis of a CBCT image. a) providing treatment beam absorption data which describe the absorption properties of the at least part of the body with respect to absorbing the treatment radiation, and the relative position between the at least part of the body and the treatment arrangement; b) providing treatment beam data which describe radiation properties of the at least one treatment beam; c) providing condition data which describe a condition for treating the at least part of the body; d) determining an optimum relative position between the treatment arrangement and the at least part of the body on the basis of the condition data, the treatment beam data and the treatment beam absorption data,
A refrigerator preservation control method, wherein a refrigerator comprises a cabinet, in which is defined at least one storage compartment; and a freezer preservation chamber, arranged in the at least one storage compartment; and the method comprises: detecting whether an object to be handled is placed in the freezer preservation chamber; if yes, acquiring the temperature of the object to be handled; acquiring a preset correspondence between temperatures of the object to be handled and operating modes of the refrigerator; and controlling the refrigerator to operate in an operating mode corresponding to the acquired temperature of the object to be handled, wherein the operating modes comprise a quick freezing mode, configured to refrigerate the freezer preservation chamber to reduce the temperature of the object to be handled; and a quick thawing mode, configured to thaw the freezer preservation chamber to increase the temperature of the object to be handled; and the step of controlling the refrigerator to operate in the operating mode corresponding to the temperature of the object to be handled comprises: controlling, when the temperature of the object to be handled is greater than a first preset temperature threshold value, the refrigerator to operate in the quick freezing mode; and controlling, when the temperature of the object to be handled is lower than a second preset temperature threshold value, the refrigerator to operate in the quick thawing mode, the first preset temperature threshold value being greater than the second reset temperature threshold value. detecting whether an object to be handled is placed in the freezer preservation chamber; if yes, acquiring the temperature of the object to be handled; acquiring a preset correspondence between temperatures of the object to be handled and operating modes of the refrigerator; and controlling the refrigerator to operate in an operating mode corresponding to the acquired temperature of the object to be handled, wherein the operating modes comprise a quick freezing mode, configured to refrigerate the freezer preservation chamber to reduce the temperature of the object to be handled; and a quick thawing mode, configured to thaw the freezer preservation chamber to increase the temperature of the object to be handled; and the step of controlling the refrigerator to operate in the operating mode corresponding to the temperature of the object to be handled comprises: controlling, when the temperature of the object to be handled is greater than a first preset temperature threshold value, the refrigerator to operate in the quick freezing mode; and controlling, when the temperature of the object to be handled is lower than a second preset temperature threshold value, the refrigerator to operate in the quick thawing mode, the first preset temperature threshold value being greater than the second reset temperature threshold value.
Sports footwear such as, e.g., a ski boot, cross-country ski boot, hiking boot or the like, which is assembled of several components and comprises an upper, a tip or front cap and a heel or rear cap as well as a sole part, said sole part comprising a wedge with a preformed foot bed, with said components being connected to each other, preferably glued together, characterized in that said tip or front cap and said heel or rear cap (4 and 6, respectively) are each designed as a three-dimensional, preformed, injection-molded plastic part, with said wedge of said sole part being connected to an insole provided at least in the forefoot region, and with said rear cap being connected to said wedge and said front cap being connected to said insole.
A use of an aqueous based wellbore fluid for preventing wellbore fluid loss into the formation and buildup of a filtercake to control filtration loss into a permeable formation said aqueous based wellbore fluid comprising: at least one copolymer formed from at least one natural polymer monomer and at least one latex monomer being at least one styrene-butadiene copolymer; and an aqueous base fluid. at least one copolymer formed from at least one natural polymer monomer and at least one latex monomer being at least one styrene-butadiene copolymer; and an aqueous base fluid.
A method performed by a first application server located in a first edge cloud, the method comprising: sending, to a core network entity for mobility management, a request to subscribe to handover event notifications for a user equipment, the request including an identity for the user equipment, wherein the handover event notifications for the user equipment relate to handovers from a first service area of the first edge cloud to a second service area of a second edge cloud, wherein the second service area is served by a second application server located in the second edge cloud, wherein the core network entity for mobility management is configured to participate in the handover signalling of the user equipment; receiving, from the core network entity for mobility management, a handover event notification indicating that the user equipment is moving from the first service area to the second service area, wherein the first application server is running an application session for the user equipment; and transferring the application session to the second application server. sending, to a core network entity for mobility management, a request to subscribe to handover event notifications for a user equipment, the request including an identity for the user equipment, wherein the handover event notifications for the user equipment relate to handovers from a first service area of the first edge cloud to a second service area of a second edge cloud, wherein the second service area is served by a second application server located in the second edge cloud, wherein the core network entity for mobility management is configured to participate in the handover signalling of the user equipment; receiving, from the core network entity for mobility management, a handover event notification indicating that the user equipment is moving from the first service area to the second service area, wherein the first application server is running an application session for the user equipment; and transferring the application session to the second application server.
An applicator assembly comprising: a medical applicator (10, 51) configured for applying a curable liquid substance, and including at least one cannula hub for providing therethrough a curable liquid substance; a lumen inlet (25, 65) for receiving therein gas from an exterior source, and a tubular body (15, 55), wherein the tubular body is in fluid communication with the lumen inlet; and characterised by an addition (30, 70) to said medical applicator, the addition comprising a turbulating unit (35, 75) configured for mixing said gas with a powder stored in a vial, the turbulating unit having: - an inlet port (37a, 77a) connectable to the exterior source; - an outlet port (37b, 77b) connectable to the lumen inlet of the medical applicator; and - a spike member configured for being entered into the vial and having a first passage for providing fluid communication between said inlet port and the vial, and a second passage for providing fluid communication between the vial and said outlet port; wherein the tubular body is configured for applying said substance and a mixture of said gas and said powder on a surface, whereby the assembly of the addition with the medical applicator enables delivery of the curable liquid substance and the powder on the surface. a medical applicator (10, 51) configured for applying a curable liquid substance, and including at least one cannula hub for providing therethrough a curable liquid substance; a lumen inlet (25, 65) for receiving therein gas from an exterior source, and a tubular body (15, 55), wherein the tubular body is in fluid communication with the lumen inlet; and characterised by an addition (30, 70) to said medical applicator, the addition comprising a turbulating unit (35, 75) configured for mixing said gas with a powder stored in a vial, the turbulating unit having: - an inlet port (37a, 77a) connectable to the exterior source; - an outlet port (37b, 77b) connectable to the lumen inlet of the medical applicator; and - a spike member configured for being entered into the vial and having a first passage for providing fluid communication between said inlet port and the vial, and a second passage for providing fluid communication between the vial and said outlet port; wherein the tubular body is configured for applying said substance and a mixture of said gas and said powder on a surface, whereby the assembly of the addition with the medical applicator enables delivery of the curable liquid substance and the powder on the surface. - an inlet port (37a, 77a) connectable to the exterior source; - an outlet port (37b, 77b) connectable to the lumen inlet of the medical applicator; and - a spike member configured for being entered into the vial and having a first passage for providing fluid communication between said inlet port and the vial, and a second passage for providing fluid communication between the vial and said outlet port;
A solid pharmaceutical dosage form for oral administration comprising: (a) a core comprising at least one active pharmaceutical ingredient selected from the group consisting of anesthetics, antibiotics, anti-inflammatory drugs, anti-migraine drugs, antiseptics, anti-diarrhea drugs, decongestants, erectile dysfunction drugs, mucolytics, muscle relaxants, anti-allergy drugs, stimulants, substances for treatment of oral malodour, antihistamines, expectorants and cough suppressants, wherein the core of the solid dosage form has a weight from 50 mg to 2000 mg, and (b) a film coating having a weight of from 1% to 15% of the weight of the core, comprising at least one film-forming polymer wherein the at least one film-forming polymer comprises hydroxypropyl methylcellulose, at least one flavoring agent, and at least one sweetener, wherein the film coating is devoid of any API, wherein the solid pharmaceutical dosage form comprises at least two APIs, wherein the solid pharmaceutical dosage form optionally comprises one or more inactive component, wherein said solid pharmaceutical dosage form is selected from the group consisting of a lozenge, a sublingual tablet, a buccal tablet and an orally disintegrating tablet, whereby upon administration the API is capable of being completely dissolved in the oral cavity, wherein one or more organoleptically disturbing sensations induced by one or more of the APIs and/or of inactive components of the solid pharmaceutical dosage form is/are reduced by constituents of said film coating, and wherein said dosage form does not contain nicotine. (a) a core comprising at least one active pharmaceutical ingredient selected from the group consisting of anesthetics, antibiotics, anti-inflammatory drugs, anti-migraine drugs, antiseptics, anti-diarrhea drugs, decongestants, erectile dysfunction drugs, mucolytics, muscle relaxants, anti-allergy drugs, stimulants, substances for treatment of oral malodour, antihistamines, expectorants and cough suppressants, wherein the core of the solid dosage form has a weight from 50 mg to 2000 mg, and (b) a film coating having a weight of from 1% to 15% of the weight of the core, comprising at least one film-forming polymer wherein the at least one film-forming polymer comprises hydroxypropyl methylcellulose, at least one flavoring agent, and at least one sweetener, wherein the film coating is devoid of any API, wherein the solid pharmaceutical dosage form optionally comprises one or more inactive component, wherein said solid pharmaceutical dosage form is selected from the group consisting of a lozenge, a sublingual tablet, a buccal tablet and an orally disintegrating tablet, whereby upon administration the API is capable of being completely dissolved in the oral cavity, wherein one or more organoleptically disturbing sensations induced by one or more of the APIs and/or of inactive components of the solid pharmaceutical dosage form is/are reduced by constituents of said film coating, and wherein said dosage form does not contain nicotine.
An extensible and retractable arm mechanism, comprising: a first structure group formed by coupling a plurality of first structures and a second structure group formed by coupling a plurality of second hollow structures, wherein each of the first structures comprises lock parts (22b1) and (22b2) for fixing the second structures to the first structures, and when the first structure group and the second structure group extend, the lock part fixes the second structures to the first structures, wherein the lock parts (22b1) and (22b2) are made of a through-hole provided on the first structures and fitting part comprising lock pins (26b1) and (26b2) for lock part receivers (27b1) and (27b2) are provided on the second hollow structures, wherein, the first structure group and the second structure group are joined, the lock parts (22b1) and (22b2) of the first structure group are interposed between the lock part receivers (27b1) and (27b2) of adjacent second structures and the lock pins (26b1) and (26b2) which are fitted into the through-hole of the lock parts (22b1) and (22b2). a first structure group formed by coupling a plurality of first structures and a second structure group formed by coupling a plurality of second hollow structures, wherein each of the first structures comprises lock parts (22b1) and (22b2) for fixing the second structures to the first structures, and when the first structure group and the second structure group extend, the lock part fixes the second structures to the first structures, wherein the lock parts (22b1) and (22b2) are made of a through-hole provided on the first structures and fitting part comprising lock pins (26b1) and (26b2) for lock part receivers (27b1) and (27b2) are provided on the second hollow structures, wherein, the first structure group and the second structure group are joined, the lock parts (22b1) and (22b2) of the first structure group are interposed between the lock part receivers (27b1) and (27b2) of adjacent second structures and the lock pins (26b1) and (26b2) which are fitted into the through-hole of the lock parts (22b1) and (22b2).
Fuel tank for a truck, with a peripheral wall, which together with end walls constitutes at least one receptacle for receiving a liquid or gaseous medium, wherein three baffles are provided inside the peripheral wall, wherein the baffles comprise a means (19, 24) for fixing inside the peripheral wall, which means can be connected to an outer fixing means through the peripheral wall, characterized in that the baffles comprise lugs as a fixing means, which lugs extend vertically from the surface of the baffles parallel to the peripheral wall, and the baffles are connected together via longitudinal struts.
An explosion proof ultrasonic detector, comprising: a metal enclosure configured to face ultrasound pressure waves; a sense element, wherein the sense element is attached to the metal enclosure via solder; a compression element, wherein the compression element is electrically conductive; and a printed circuit board, wherein the metal enclosure is directly attached to the PCB, which contacts the compression element, thereby compressing the sense element via the compression element to connect electrically to the sense element and to provide explosion protection. a metal enclosure configured to face ultrasound pressure waves; a sense element, wherein the sense element is attached to the metal enclosure via solder; a compression element, wherein the compression element is electrically conductive; and a printed circuit board, wherein the metal enclosure is directly attached to the PCB, which contacts the compression element, thereby compressing the sense element via the compression element to connect electrically to the sense element and to provide explosion protection.
Apparatus for processing an image of a surrounding of a vehicle comprising the following features: - an image generator (14a, 14b) being a camera and configured for generating an image, the image having at least a first and a second portion each with a contiguous array of pixels, the first and second portions being different from each other and the first portion of the image being generated for further processing earlier than the second portion of the image, wherein the image generator is configured to transfer, to an image processor, the first portion while generating the second portion; and - the image processor being configured for processing the first and second portions of the image in order to process the image, wherein the image processor is furthermore configured for processing said first portion of said image while said second portion of said image is not yet available to the image processor. - an image generator (14a, 14b) being a camera and configured for generating an image, the image having at least a first and a second portion each with a contiguous array of pixels, the first and second portions being different from each other and the first portion of the image being generated for further processing earlier than the second portion of the image, wherein the image generator is configured to transfer, to an image processor, the first portion while generating the second portion; and - the image processor being configured for processing the first and second portions of the image in order to process the image, wherein the image processor is furthermore configured for processing said first portion of said image while said second portion of said image is not yet available to the image processor.
Buprenorphine for use in a method of preventing or treating an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine to prevent or treat the adverse pharmacodynamic response induced by the administration of another opioid, wherein the other opioid is administered in an effective amount to provide an analgesic effect, and wherein the patient is administered the buprenorphine concurrently with the other opioid.
A compound for use in the treatment of hyperphosphatemia in a patient in need thereof, wherein the compound is substantially active in the gastrointestinal tract to inhibit transport of phosphate ions (Pi), and wherein the compound is a guanylate cyclase C receptor (GC-C) agonist.
A composition comprising a plurality of discrete multiwall carbon nanotubes, wherein the discrete multiwall carbon nanotubes comprise an interior and exterior surface, the interior surface comprising an interior surface oxidized species content and the exterior surface comprising an exterior surface oxidized species content, wherein the interior surface oxidized species content is at least 0.01 up to 3 weight percent relative to carbon nanotube weight and differs from the exterior surface oxidized species content by at least 20%, and as high as 100%, wherein the oxidized species is selected from the group consisting of carboxylic acids, phenols, aldehydes, ketones, ether linkages, and combinations thereof.
A method for reducing blockiness of at least one film grain block, comprising: establishing at least one parameter indicating film grain size in the block; and reducing the film grain blockiness in accordance with the at least one parameter indicating film grain size in the block, the reducing is performed by one of downscaling the film grain block along at least one block edge and deblocking filtering the film grain block across the at least one block edge.
An implant system for use in an intestinal lumen, comprising: a proximal anchor (12, 12a) with a distal end and inner and outer sides, the anchor being self-expandable from a radially compressed position to a radially expandable position for engagement with a wall of the intestinal lumen; and a flexible sleeve (14, 14a, 14b) coupled to the anchor at one sleeve end characterized in that the one sleeve end wraps around the distal end of the anchor, covering the anchor's distal end and outer side, wherein said sleeve is deployable through the anchor such that the inner and outer sides of the anchor are covered by the sleeve when deployed.
A granule comprising a core and a protective coating, wherein: (a) the core comprises an amylase, a lipase, a protease a cellulase, a mannanase or a pectate lyase in an amount of 0.0005-50% by dry weight relative to the core, and (b) the core or the coating comprises a thiosulfate or methionine in an amount of 0.1-10% by weight relative to the core, and (c) the core comprises a salt of Mg or Zn in an amount of 0.1-15% as anhydrous salt by weight of the core, and (d) the core or the coating comprises an acidic buffer comprising a mixture of citric acid and a citrate in an amount of 0.1-10% by weight relative to the core, and (e) the coating comprises a salt wherein the coating makes up 5-70% by weight relative to the core and comprises at least 60% by weight w/w of a salt having a constant humidity at 20°C of at least 60%. (a) the core comprises an amylase, a lipase, a protease a cellulase, a mannanase or a pectate lyase in an amount of 0.0005-50% by dry weight relative to the core, and (b) the core or the coating comprises a thiosulfate or methionine in an amount of 0.1-10% by weight relative to the core, and (c) the core comprises a salt of Mg or Zn in an amount of 0.1-15% as anhydrous salt by weight of the core, and (d) the core or the coating comprises an acidic buffer comprising a mixture of citric acid and a citrate in an amount of 0.1-10% by weight relative to the core, and (e) the coating comprises a salt wherein the coating makes up 5-70% by weight relative to the core and comprises at least 60% by weight w/w of a salt having a constant humidity at 20°C of at least 60%.